Pacific Shuanglin Bio-pharmacy Co., LTD
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 69.4 | -100% | 68.77 | -100% |
| P/S |
|
0 | 6.51 | -100% |
|
|
| P/BV |
|
0 | 3.96 | -100% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
0 | 11.85 | -100% |
|
|
| Ev/S |
|
0 | 5.98 | -100% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0 | 0.0396 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 20.39 | -100% | 23.58 | -100% |
| ROE |
|
0 | 11.95 | -100% |
|
|
| ROA |
|
0 | 5.4 | -100% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
0 | 16.23 | -100% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | 14.63 | -100% | 0.3344 | -100% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0 | 3.6 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.83 | -100% | 0.2951 | -100% |
| Number of years of dividend growth |
|
1 | 1.44 | -30.43% | ||
| DSI |
|
0.8333 | 0.9113 | -8.56% |
|
|
| Average dividend growth |
|
-13.57 | 10.4 | -230.53% |
|
|
| Average percentage for 5 years |
|
0.2951 | 1.14 | -74.16% |
|
|
| Average percentage for payments |
|
82.89 | 44.8 | 85.02% |
|
|
| Difference from average difference in sector |
|
-1.83 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
154.32 | 61.43 | 151.21% | ||
| Growth impulse Ebitda in 5 years |
|
362.66 | 158.62 | 128.63% | ||
| Growth impulse Net Income in 5 years |
|
281.5 | 66.93 | 320.59% | ||
| Growth impulse FCF in 5 years |
|
101.52 | 248.41 | -59.13% | ||
| Growth impulse EPS in 5 years |
|
164.17 | 73.29 | 124% |
IP Score
5.09/10
